Lonza Group AG (LZAGY) Financials
LZAGY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 22.6 billion | 12.5 billion |
| Dec. 31, 2025 | 23.9 billion | 12.3 billion |
| June 30, 2025 | 23.7 billion | 12.8 billion |
| Dec. 31, 2024 | 21.8 billion | 11.4 billion |
LZAGY Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 102.3 million | ? |
| Dec. 31, 2025 | 76.6 million | ? |
| June 30, 2025 | -334.3 million | 40.4 million |
| Dec. 31, 2024 | -28.8 million | ? |
LZAGY Net Income
| Date | Net Income |
|---|---|
| June 30, 2026 | 721.2 million |
| Dec. 31, 2025 | 603.7 million |
| June 30, 2025 | 537.3 million |
| Dec. 31, 2024 | 340.6 million |
LZAGY Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 602.1 million | 4.2 billion | - |
| Dec. 31, 2025 | 906.2 million | 4.9 billion | 447.4 million |
| June 30, 2025 | 1.1 billion | 5.3 billion | - |
| Dec. 31, 2024 | 1.9 billion | 4.7 billion | 453.4 million |
LZAGY Shares Outstanding
LZAGY Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 731.3 million | - | 618.9 million | - |
| Dec. 31, 2025 | 937.0 million | - | 397.5 million | - |
| June 30, 2025 | 785.6 million | - | 841.3 million | - |
| Dec. 31, 2024 | 879.1 million | 227.8 million | 447.9 million | 286.4 million |
LZAGY Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 4.3 billion | 2.6 billion |
| Dec. 31, 2025 | 3.7 billion | 2.4 billion |
| June 30, 2025 | 4.5 billion | 2.9 billion |
| Dec. 31, 2024 | 3.9 billion | 2.7 billion |
LZAGY
Price: $69.98
Dividend Yield: 0.79%
Forward Dividend Yield: 0.19%
Payout Ratio: 42.30%
Dividend Per Share: 0.57 USD
Earnings Per Share: 1.89 USD
P/E Ratio: 36.06
Exchange: PNK
Sector: Healthcare
Industry: Diagnostics & Research
Country: Switzerland
Volume: 52072
Ebitda: 1.0 billionMarket Capitalization: 51.4 billion
Average Dividend Frequency: 1
Years Paying Dividends: 18
DGR3: 11.65%
DGR5: 30.00%
DGR10: 30.00%